General Description
HFSA Heart Failure Seminar: Focus on Sleep
Original Seminar Date September 14, 2023
5:30 pm ET - 7:00 pm ET
Program Overview
The HFSA Heart Failure: Focus on Sleep, Failure to Sleep, features a multidisciplinary panel of HF experts who are presenting a case-based program that is designed to provide the most current information on the diagnosis and utilization of emerging, novel, and current treatments for the management of sleep-disordered breathing (SDB) in patients with heart failure (HF). Among the topics that will be discussed in this program are the physiology and pathophysiology of SDB in HF, pathways for the screening and diagnosis of SBD, treatment options for CSA and OSA, and the impact of pharmacotherapies for insomnia and SBD for the HF population.
This program is part of the HFSA’s ongoing Focus On seminar series which brings together healthcare providers (HCPs), including researchers, cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure. This case-based program is being developed by practicing clinicians and is designed to provide the most current information on the pathophysiology, diagnosis, and management of HF patients with SDBs.
Target Audience
This activity is intended for cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
Program Planners and Faculty
Program PLanners:
- Jennifer Cook, MD
- Ann Laramee, MS, ANP-BC, ACNS, CHFN, ACHPN, FHFSA
- Erika M. Schoenborn, PharmD, BCCP, CPP
Faculty:
- Sogol Javaheri, MD
- Gregory Jackson, MD
- Atul Malhotra, MD
Learning Objectives and Knowledge Gaps
- Explain sleep physiology and pathophysiology in heart failure
- Identify pathways for the screening and diagnosis of sleep disorders in the heart failure population
- Review the treatment options for obstructive and central sleep apnea
- Discuss the use of pharmacotherapies for insomnia and sleep disorders in the heart failure population
Agenda
- Welcome Remarks - J. Cook
- Case Discussion - Insomnia
- Didactic Presentation - Pathophysiology - A. Malhotra
- Didactic Presentation - Central and Obstructive - S. Javaheri
- Didactic Presentation - Cardiology and Sleep Disorder Breathing - G. Jackson
- Case Discussion - Diagnosis and Treatment
- Closing Remarks - J. Cook
Faculty Disclosures/Off-Label Disclosure
Faculty Disclosures
The Heart Failure Society of America (HFSA) is committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24 months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity.
Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interests have been resolved in accordance with the ACCME Updated Standards for Commercial Support.
The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest:
- Jennifer Cook, MD
- Ann Laramee, MS, ANP-BC, ACNS, CHFN, ACHPN, FHFSA
- Erika M. Schoenborn, PharmD, BCCP, CPP
The following faculty and/or accreditors with ability to control content for this activity have listed the below disclosures:
- Sogol Javaheri, MD – Grant: Zoll Medical, Massachusetts Technology Collaborative
- Gregory Jackson, MD -- Honorarium: Respicardia
Off-Label Disclosure
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
Accreditation Statement
In support of improving patient care, the Heart Failure Society of American is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Heart Failure Society of America designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Successful completion of this CME activity, includes participation in the post-course evaluation.
This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 1.5 contact hours (which includes 1.5 hours of nursing pharmacology).
Supporters
The Heart Failure Society of America acknowledge Zoll and Inspire for providing an independent educational grant to support the Heart Failure Seminar: Focus on Sleep.